RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
EpicentRx, Inc.
Actuate Therapeutics Inc.
Atreca, Inc.
Columbia University
Western Regional Medical Center
Santa Maria Biotherapeutics
National Institute of Cancerología